Matthew Fry

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Matthew Fry
Non-Executive Director / Paradigm Biopharmaceuticals

Mr Fry joins the Paradigm board with more than 25 years in business creation, strategy, and expansion in healthcare and medical diagnostics globally. He is currently the CEO, Managing Director and Founder of AM Diagnostics Pty Ltd, a manufacturer and distributor of world class medical diagnostic products. With his global network within the biotechnology and medical diagnostic industry, Matthew brings both entrepreneurial spirit and substantial experience in product commercialisation. As CEO of AM Diagnostics during the COVID pandemic. Matthew has experience with global regulatory agencies, in particular the Australian TGA and US FDA.

Lists and Charts

Roles

2024
Non-Executive Director
Paradigm Biopharmaceuticals
Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
420th Global Masters Fund 32.23% 12.99%
421st IRESS 32.15% -3.44%
422nd Paradigm Biopharmaceuticals 32.05% -32.62%
423rd 92 Energy 32% 0%
424th Harvest Technology Group 31.98% -10.12%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

03/12/24
Other
Paradigm Biopharmaceuticals
Total value as at the date of the transaction
Powered by Morningstar ®

Person Activity

 NEW ROLE: Non-Executive Director, Paradigm Biopharmaceuticals 07 Aug 2024

Related Information

Access to our data for Matthew Fry is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Matthew Fry is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.

X